Adverum Biotechnologies
ADVM
ADVM was delisted on the 8th of December, 2025.
96 hedge funds and large institutions have $255M invested in Adverum Biotechnologies in 2015 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 50 increasing their positions, 14 reducing their positions, and 38 closing their positions.
257% more repeat investments, than reductions
Existing positions increased: 50 | Existing positions reduced: 14
116% more call options, than puts
Call options by funds: $22.3M | Put options by funds: $10.3M
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
15% less funds holding
Funds holding: 113 → 96 (-17)
45% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 38
60% less capital invested
Capital invested by funds: $642M → $255M (-$387M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$29.7M |
| 2 |
CCM
Cadian Capital Management
New York
|
+$22.8M |
| 3 |
FCM
Frontier Capital Management
Boston,
Massachusetts
|
+$17.4M |
| 4 |
LCM
Laurion Capital Management
New York
|
+$12.7M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
+$10.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
-$85.8M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$21.3M |
| 3 |
TCP
Tourbillon Capital Partners
New York
|
-$17.9M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$15.4M |
| 5 |
RIM
RS Investment Management
San Francisco,
California
|
-$13.8M |
ADVM Hedge Fund Activity: Q2 2015 in Review
96 of the 3,713 institutional investors tracked by Wall St. Rank reported a position in Adverum Biotechnologies (ADVM) for Q2 2015, worth a combined $255M — down 60% from $642M a quarter earlier.
Sellers outnumbered buyers: 38 funds closed out of ADVM and 21 opened new positions — a net loss of 17 holders — while 14 trimmed existing stakes and 50 added.
The largest buyer was Millennium Management, adding an estimated $29.7M. The largest seller was Deerfield Management, exiting entirely with an estimated $85.8M sold.
- 96 institutional investors held Adverum Biotechnologies (ADVM) as of Q2 2015, down from 113 in Q1 2015.
- Funds reported $255M of Adverum Biotechnologies stock for Q2 2015, down 60% quarter-over-quarter.
- 21 funds opened new Adverum Biotechnologies positions in Q2 2015 and 38 closed out, a net change of -17 holders.
- The largest Adverum Biotechnologies buyer in Q2 2015 was Millennium Management, an estimated $29.7M added.
- The largest Adverum Biotechnologies seller in Q2 2015 was Deerfield Management, an estimated $85.8M sold.
Based on aggregated 13F filings for Q2 2015.